Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up

Background Testicular adrenal rest tumors (TARTs) are found in 30–94% of adult males with congenital adrenal hyperplasia (CAH). We sought to explore TART appearance through yearly ultrasound examination of testes in young boys with CAH, and its association with metabolic control and genetic mutations. Methods Twenty-five boys with 21-hydroxylase deficiency in the age group 4–18 years diagnosed during the period 2001–2016 were included in the study. ACTH, 17-hydroxyprogesterone, androstenedione and testosterone were measured at 4-month intervals. Growth and BMI were assessed at the time of evaluation. PCR/ACRS method was used for CYP21A2 gene analysis. Testicular ultrasound examination was performed yearly. Results TARTs were detected by ultrasound in 8 children at the age of 6–16 years (13.2 years average). Five had salt-wasting form, two had simple virilizing form and one had non-classic form of CAH. Significant differences in the17OHP and androstenedione levels were detected between the boys, adherent and non-adherent to therapy. Inadequate metabolic control was not different in boys with and without TART (11/17 and 5/8 respectively). No significant difference was detected in the distribution of genetic mutations or adherence to therapy between patients with and without TARTs. One patient had a mutation not reported thus far in TART and another developed leukemia. Conclusion TART is not rare in young boys with CAH, irrespective of the specific mutation or metabolic control. Ultrasound screening helps timely diagnosis and adjustment of therapy.

[1]  P. Span,et al.  Gonadal function in adult male patients with congenital adrenal hyperplasia. , 2018, European journal of endocrinology.

[2]  H. Falhammar,et al.  Reduced Frequency of Biological and Increased Frequency of Adopted Children in Males With 21‐Hydroxylase Deficiency: A Swedish Population‐Based National Cohort Study , 2017, The Journal of clinical endocrinology and metabolism.

[3]  Z. Grubic,et al.  Testicular adrenal rest tumors in congenital adrenal hyperplasia—cross-sectional study of 51 Croatian male patients , 2017, European Journal of Pediatrics.

[4]  H. Yoo,et al.  Long-term Consequences of Congenital Adrenal Hyperplasia due to Classic 21-hydroxylase Deficiency in Adolescents and Adults. , 2017, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[5]  H. Yoo,et al.  Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency , 2016, Annals of pediatric endocrinology & metabolism.

[6]  Jacques Young,et al.  Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey. , 2015, The Journal of clinical endocrinology and metabolism.

[7]  Samson O Oyibo,et al.  Large testicular adrenal rest tumours in a patient with congenital adrenal hyperplasia , 2014, Endocrinology, diabetes & metabolism case reports.

[8]  B. Walker,et al.  Treatment and health outcomes in adults with congenital adrenal hyperplasia , 2014, Nature Reviews Endocrinology.

[9]  R. Auchus,et al.  Approach to the patient: the adult with congenital adrenal hyperplasia. , 2013, The Journal of clinical endocrinology and metabolism.

[10]  H. Falhammar,et al.  One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. , 2013, The lancet. Diabetes & endocrinology.

[11]  F. Beuschlein,et al.  Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency. , 2013, The Journal of clinical endocrinology and metabolism.

[12]  Z. Aycan,et al.  Prevalence and long‐term follow‐up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia , 2013, Clinical endocrinology.

[13]  A. Samkari,et al.  Testicular adrenal rest “tumor” or Leydig cell tumor? A report of a challenging case with literature review , 2013, Avicenna Journal of Medicine.

[14]  M. Nishitani,et al.  Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  V. Toscano,et al.  Testicular Adrenal Rest Tumors in Patients With Congenital Adrenal Hyperplasia , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[16]  T. Sellami-Boudawara,et al.  Leydig Cell Tumor Associated with Testicular Adrenal Rest Tumors in a Patient with Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency , 2012, Case reports in urology.

[17]  H. Falhammar,et al.  Clinical outcomes in the management of congenital adrenal hyperplasia , 2012, Endocrine.

[18]  H. Falhammar,et al.  Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia , 2011, European journal of endocrinology.

[19]  H. Yoo,et al.  Testicular adrenal rest tumors in a patient with untreated congenital adrenal hyperplasia , 2011, Korean journal of pediatrics.

[20]  P. Petronella,et al.  Congenital adrenal hyperplasia and Leydig cell tumor of testis. Case report and review of literature. , 2010, Annali italiani di chirurgia.

[21]  V. Montori,et al.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[22]  J. Connell,et al.  Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients , 2010, The Journal of clinical endocrinology and metabolism.

[23]  F. Beuschlein,et al.  Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. , 2010, The Journal of clinical endocrinology and metabolism.

[24]  F. Beuschlein,et al.  High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  F. Sweep,et al.  Testicular adrenal rest tumours in congenital adrenal hyperplasia. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[26]  F. Sweep,et al.  Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2007, European journal of endocrinology.

[27]  P. Span,et al.  Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. , 2007, The Journal of clinical endocrinology and metabolism.

[28]  J. Popović,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2005, Journal for specialists in pediatric nursing : JSPN.

[29]  G. Heinze,et al.  Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  C. Sweep,et al.  High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. , 2001, The Journal of clinical endocrinology and metabolism.

[31]  A. Braun,et al.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. , 2000, The Journal of clinical endocrinology and metabolism.

[32]  D. Merke,et al.  Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings. , 1999, AJR. American journal of roentgenology.

[33]  M. Hiriart,et al.  Experimental and Clinical Endocrinology and Diabetes , 1997 .

[34]  D. Canning,et al.  Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome. , 1997, The Journal of urology.

[35]  M. New,et al.  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. , 1995, Journal of Clinical Endocrinology and Metabolism.

[36]  M. Tusié-Luna,et al.  A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. , 1991, Molecular endocrinology.

[37]  P. Besch,et al.  ACTIVATION OF TESTICULAR ADRENAL REST TISSUE BY PROLONGED EXCESSIVE ACTH PRODUCTION. , 1963, The Journal of clinical endocrinology and metabolism.

[38]  M. Güven,et al.  Testicular Adrenal Rest Tumor , 2018 .

[39]  M. Kocova,et al.  Genotype-Phenotype Correlation in CAH Patients with Severe CYP21A2 Point Mutations in the Republic of Macedonia , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[40]  M. Kocova,et al.  A p.P30L Mutation at the CYP21A2 Gene in Macedonian Patients with Nonclassical Congenital Adrenal Hyperplasia , 2010 .